Endovenous laser ablation of saphenous vein is an effective treatment modality for lower extremity varicose veins

Kavuturu, S.; Girishkumar, H.; Ehrlich, F.
August 2006
American Surgeon;Aug2006, Vol. 72 Issue 8, p672
Academic Journal
journal article
We present our first experiences with the use of a new minimally invasive treatment of lower extremity varicose veins. We studied the occlusion rates of the great saphenous vein (GSV) with laser ablation, its failure rates, and its complications. Sixty-six limbs in 62 consecutive patients were treated and followed-up for 1 year. All of the patients had incompetent GSV proven by means of duplex scanning. The GSV segment from 2 cm distal to the sapheno-femoral junction to just above the knee was ablated by using laser energy. In addition, all patients had stab avulsions of the varicose veins of the leg with Crochet hooks. All patients were followed postoperatively on the 3rd day, 1 month, 3 months, and 1 year after surgery. All patients were treated as day-case surgeries. Among 62 patients studied, 46 patients were women (74%) and 16 were men (26%). The median age of the patients was 53 years (range 28-69 years). Median operation time was 65 min (range 40-140 min). Successful treatment (total obliteration of the GSV on duplex) was accomplished in 64 of 66 limbs (97%). In two cases, recanalization of the lower one-third of the treated segment of the GSV was noted after 3 months. There were no instances of neuropathy or skin burn. Endovenous laser ablation of varicose veins is effective in inducing thrombotic vessel occlusion and is associated with only minor adverse effects. The procedure seems to be a promising alternative for surgical stripping of the GSV.


Related Articles

  • Endovenous Laser Ablation (EVLA) in Patients With Varicose Great Saphenous Vein (GSV) and Incompetent Saphenofemoral Junction (SFJ): An Ambulatory Single Center Experience. Zafarghandi, Mohammad Reza; Akhlaghpour, Shahram; Mohammadi, Halimeh; Abbasi, Ali // Vascular & Endovascular Surgery;Apr/May2009, Vol. 43 Issue 2, p178 

    Objectives: To evaluate treatment results for varicose great saphenous vein (GSV) using endovenous laser ablation (EVLA) in an ambulatory single center. Material and methods: We prospectively studied 77 limbs with varicose GSV in 74 patients who were treated using 980-nm EVL with a 600-mm laser...

  • Connective Tissue Accumulation in the Muscle Layer in Normal and Varicose Saphenous Veins. Porto, Luís Cristóvão; da Silveira, Paulo Roberto M.; de Carvalho, Jorge José; Brandão Panico, Marília Duarte // Angiology;Mar1995, Vol. 46 Issue 3, p243 

    Varicose veins alternate areas of phlebosclerosis and hypertrophy of the vein wall. In this study, samples of long saphenous veins obtained from patients submitted for aortocoronary saphenous vein graft or for surgical resection of varicose saphenous veins were examined. Histologic changes in...

  • Radiofrequency ablation (VNUS closure) does not cause neo-vascularisation at the groin at one year: Results of a case controlled study. Kianifard, B.; Holdstock, J. M.; Whiteley, M. S. // Surgeon (Edinburgh University Press);Apr2006, Vol. 4 Issue 2, p71 

    Background: Despite adequate training in the surgical treatment of varicose veins, recurrence continues to be a problem and a burden to the vascular services. A major cause of recurrence is reported to be neo-vascularisation at the sapheno-femoral junction (SFJ). The aim of this study was to...

  • LOWER EXTREMITY VARICOSIS ORIGINATING FROM THE PELVIS. Massell, Theodore B.; Heringman, Craig; Greenstone, S. M. // Angiology;Feb1966, Vol. 17 Issue 2, p121 

    A syndrome has been described comprising varicose veins of the lower extremity arising from the internal iliac vein. The condition occurs in multiparous women, arises in pregnancy, and tends to remission after delivery. Subsequent pregnancies cause severe exacerbations and each menstrual period...

  • Long-Term Recurrence and Nerve Injury After Total and Partial Stripping of the Great Saphenous Vein by External Phleboextractor. Canonico, Silvestro; Luminello, Felice; Mainelli, Rosa; Canonico, Raffaele; Campitiello, Ferdinando // Vascular Surgery;Mar/Apr2000, Vol. 34 Issue 2, p163 

    The objective of this study was to assess the efficacy of an external phleboextractor (EP) in improving the results of total and short stripping of the great saphenous vein (GSV) with particular reference to saphenous nerve injury occurring during the operations. Two hundred fifty-seven...

  • Venous Insufficiency at Work. Hobson, John // Angiology;Jul1997, Vol. 48 Issue 7, p577 

    Chronic venous disease of the lower limbs is one of the most common conditions affecting humankind. It has been postulated that certain workplace conditions may be risk factors for venous insufficiency and varicose veins in particular. This paper examines the evidence for a link between...

  • Closure technique outperforms stripping. Jesitus, John // Cosmetic Surgery Times;Jan/Feb2005, Vol. 8 Issue 1, p16 

    This article reports that a new minimally invasive treatment for varicose veins offers a higher success rate, with less pain and downtime than commonly performed stripping procedures. The VNUS Closure technique is indicated for patients with varicosities arising from the greater saphenous vein....

  • Great gams for grands. Muse, Debbie // Grand Magazine;Nov/Dec2007, Vol. 3 Issue 6, p26 

    The article offers clinical information on varicose veins. It describes the manifestation of varicose and spider veins, along with their clinical management and relation to leg fatigue. It explains the physiological flow of blood in leg muscles and veins, including the problems associated with...

  • Sequential Injection of 3% Sodium Tetradecyl Sulfate and 20% Sodium Chloride in the Treatment of Refractory Varicosity of the Greater Saphenous Vein. Miller, Dennis; Biegeleisen, K. // Journal of Dermatologic Surgery & Oncology;May94, Vol. 20 Issue 5, p329 

    BACKGROUND. American practitioners of sclerotherapy are limited by United States Food and Drug Administration (FDA) restrictions. The strangest FDA-approved sclerosant is sodium tetradecyl sulfate. In the United States, when a varicose vein is refractory to treatment with this drug, there...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics